DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹276 Cr | ₹-627 Cr | ₹120 Cr | ₹419 Cr | ₹414 Cr |
What is the latest Net Current Assets ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹-627 Cr |
| Mar2023 | ₹120 Cr |
| Mar2022 | ₹419 Cr |
| Mar2021 | ₹414 Cr |
How is Net Current Assets of DISHMAN CARBOGEN AMCIS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹276 Cr | Positive | |
| Mar2024 | ₹-627 Cr | Negative | |
| Mar2023 | ₹120 Cr | -71.36 | |
| Mar2022 | ₹419 Cr | 1.23 | |
| Mar2021 | ₹414 Cr | - | |
Compare Net Current Assets of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,922.0 Cr | -3.9% | 7.6% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -3.9% |
7.6% |
-25.5% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses